15575812743_f506d4a62b_k Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group. The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 different tests on a single finger prick of blood in under 15 minutes using what it calls its Maverick Detection Platform. Genalyte’s proprietary… Read More

Source: News